0000899243-18-007395.txt : 20180314 0000899243-18-007395.hdr.sgml : 20180314 20180314172821 ACCESSION NUMBER: 0000899243-18-007395 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180314 FILED AS OF DATE: 20180314 DATE AS OF CHANGE: 20180314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KANEKO YASUNORI CENTRAL INDEX KEY: 0001277503 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38419 FILM NUMBER: 18690372 MAIL ADDRESS: STREET 1: 509 ROEHAMPTON CITY: HILLS BOROUGH STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcus Biosciences, Inc. CENTRAL INDEX KEY: 0001724521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473898435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 650-489-9000 MAIL ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2018-03-14 0 0001724521 Arcus Biosciences, Inc. RCUS 0001277503 KANEKO YASUNORI C/O ARCUS BIOSCIENCES, INC. 3928 POINT EDEN WAY HAYWARD CA 94545 1 0 1 0 Common Stock 63130 I By Trust Series A Convertible Preferred Stock 3.96 Common Stock 505050 I By Kaneko Capital, LLC Series A Convertible Preferred Stock 3.96 Common Stock 252524 I By Kaneko Investments, LLC Series B Convertible Preferred Stock 7.9992 Common Stock 31253 I By Trust Series C Convertible Preferred Stock 11.6915 Common Stock 2565 I By Trust The reported security is convertible into the Issuer's Common Stock on a 1-for-1 basis at any time at the holder's election and shall automatically convert into Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date. /s/ Scott S. Paraker, Attorney-in-Fact 2018-03-14 EX-24 2 attachment1.htm EX-24 DOCUMENT

                               POWER OF ATTORNEY

      The undersigned, as a Section 16 reporting person of Arcus Biosciences,
Inc., a Delaware corporation (the "Company"), hereby constitutes and appoints
each of the persons listed on Exhibit A attached hereto, the undersigned's true
and lawful attorney-in-fact to:

      (1)  complete and execute Form ID, "Update Passphrase Confirmation" form
and Forms 3, 4 and 5 and other forms and all amendments thereto as such
attorney-in-fact shall in his or her discretion determined to be required or
advisable pursuant to Section 16 of the Securities Exchange Act of 1934 (as
amended) and the rules and regulations promulgated thereunder, or any successor
laws and regulations, as a consequence of the undersigned's ownership,
acquisition or disposition of securities of the Company; and

      (2)  do all acts necessary in order to file such forms with the Securities
and Exchange Commission, any securities exchange or national association, the
Company and such other person or agency as the attorney-in-fact shall deem
appropriate.

      The undersigned hereby ratifies and confirms all that said attorneys-in-
fact and agents shall do or cause to be done by virtue hereof. The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with the
Securities Exchange Act of 1934 (as amended).

      This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 23rd day of February, 2018.

                                        /s/ Yasunori Kaneko
                                        ---------------------------------------
                                        Yasunori Kaneko

                                      EXHIBIT A
                                      ---------
                                   Jennifer Jarrett
                                    Carolyn Tang
                                  Marcia A. Hatch
                                    Heidi Mayon
                                   Colin Conklin
                                    Scott Paraker